Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder.

Saved in:
Bibliographic Details
Title: Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder.
Authors: Azar P; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Flr 8-2775 Laurel St, V5Z 1M9, Vancouver, BC, Canada. pouya.azar@vch.ca.; Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. pouya.azar@vch.ca., Schneiderman H; School of Medicine, University College Cork, Cork, Ireland., Barron H; Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Wong JSH; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Flr 8-2775 Laurel St, V5Z 1M9, Vancouver, BC, Canada.; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Meyer M; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Clinic of Adult Psychiatry, University of Basel Psychiatric Clinics, University of Basel, Basel, Switzerland., Newman-Azar D; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Flr 8-2775 Laurel St, V5Z 1M9, Vancouver, BC, Canada., Narimani M; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Flr 8-2775 Laurel St, V5Z 1M9, Vancouver, BC, Canada.; School of Biomedical Engineering, Faculty of Medicine, Faculty of Engineering, University of British Columbia, Vancouver, BC, Canada., Ignaszewski MJ; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Flr 8-2775 Laurel St, V5Z 1M9, Vancouver, BC, Canada.; Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, British Columbia, Canada., Mathew N; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Flr 8-2775 Laurel St, V5Z 1M9, Vancouver, BC, Canada.; Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; BC Mental Health & Substance Use Services, Provincial Health Services Authority, British, Columbia, Canada., Mullen R; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Flr 8-2775 Laurel St, V5Z 1M9, Vancouver, BC, Canada.; The C4 Foundation, Coronado, CA, USA., Krausz RM; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Maharaj AR; Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Source: Addiction science & clinical practice [Addict Sci Clin Pract] 2024 Jun 18; Vol. 19 (1), pp. 50. Date of Electronic Publication: 2024 Jun 18.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101316917 Publication Model: Electronic Cited Medium: Internet ISSN: 1940-0640 (Electronic) Linking ISSN: 19400632 NLM ISO Abbreviation: Addict Sci Clin Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1940-0640
DOI:10.1186/s13722-024-00479-1